January 10, 2025 12:56 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
8 labourers still trapped in Assam's flooded mine even after 3 days of rescue ops | SC refuses to hear petitions seeking review of its same-sex marriage judgement, says there is 'no error' | 'They should wind up the alliance': Omar Abdullah on AAP-Congress fight over Delhi elections | Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes
Remdesivir
Image Credit: Unsplash

Remdesivir prices to go below Rs 3,500, assures minister: Report

| @indiablooms | Apr 15, 2021, at 12:37 am

New Delhi/IBNS: Union minister Mansukh Mandaviya said on Wednesday that the manufacturers of Remdesivir have decided to reduce the price of the anti-viral drug to less than Rs 3,500 by the end of the current week, said media reports.

This comes as India faces an acute shortage of the life-saving drug in the wake of the huge spike in Covid-19 cases, said an HT report. 

Currently, remdesivir prices are not uniform, and ranges between Rs 900 and Rs 5,000 per vial, the report added.

On April 11, India banned the export of antiviral drug Remdesivir and and Remdesivir Active Pharmaceutical Ingredients (API) due to massive jump in coronavirus cases in the country.

India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases and they are steadily increasing. This has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients. There is a potential of a further increase in this demand in the coming days,” the government had said in an order.

The order stated that  seven Indian companies are producing Remdesivir injection under a voluntary licensing agreement with US company Gilead Sciences. They have an installed capacity of about 38.80 lakh units per month.

"In light of the above, the Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,"  the statement added.

All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors to facilitate access to the drug, the statement said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.